Hemostasis Analyzers Market - Advanced Technologies, Growth and Opportunities by 2023

Hemostasis is the study of the processes involved in blood clotting (coagulation). Hematology analyzers, also known as coagulation analyzers, are instruments assisting in treating patients with blood-clotting or bleeding disorders; those with replacement heart valves; and patients who are at high risk of bleeding during surgical procedures. Hematology analyzers work on the principal of flow cytometry based on electrical impedance which aids in identifying the number and size of biological cells. Different types of hematology analyzers include cell counters, coagulators and other hematology apparatus.

Download Exclusive Sample of this Report: http://bit.ly/2fVaP4s

Flow cytometry labels, lasers and detectors are used in cell counters to differentiate cell populations classified on the basis of known cell surface markers. Increase in demand for quick and accurate results is the driving force for manufacturers to develop newer system capabilities and modern technologies in their hematology analyzers. Provision of broad range testing solutions will assist in outcome of efficient and accurate procedures. The biggest challenge for the vendors is the need to focus on customer concerns and demands along with provision of instruments with higher throughput, efficiency, accuracy and enhanced productivity at lower cost.

Hematology instruments and reagents continue to maintain strong position in healthcare industry. Market players have been observed to invest heavily in product development to offer user-friendly, more sophisticated, efficient and accurate analyzers to meet the demands of hospitals and clinics. Automated systems play a crucial role in transfusion medicines and facilitate screening of blood donors as well as quality control of blood products. The reagents segment continues to lead the market, especially in the Asian countries. The key market players in the reagents segment include Beckman Coulter, Mindray, Horiba and Transasia Bio Medical Ltd.

The global hemostasis analyzers market can be segmented based on test type, product type, end-users and geography. Test types include activated partial thromboplastin time, and prothrombin time test. Product type segment comprises fully automated analyzers and semi automated analyzers, in addition to reagents and consumables. Hospitals, clinical testing laboratories, private and academic research institutes and commercial organizations are the end users of the global hematology analyzers market. Geographically, the market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World.

North America dominates the global hematology analyzers market owing to the rising installed instrument base leading to higher sales of reagents and support services in the U.S. Beckman Coulter remains the market leader for hematology analyzers in the U.S., though its faces continuous competition from Sysmex products. Emerging markets of India, China and Brazil are registering significant growth due to increasing population, rise in healthcare expenditure and higher affordability, economic development and improving technical capabilities by these countries.

Accuracy of hematology analyzers has been enhanced by automation of systems and use of cell surface marker labels. Automated analyzers function by sampling the blood and classifying cell populations by quantification and description. This may be carried out using both electrical and optical techniques. Sophisticated hematology blood cell analyzers are enabling precise disease diagnosis at an early stage. Fully-automated systems compacted in size, easy to use, providing networking solutions and efficient data management has been the latest drift in opting for hematology analyzers.

Continuous technological advancements in molecular diagnostics, lasers, monoclonal antibodies and information technology, coupled with increase in understanding of involvement of immune system in regulating systemic diseases, is expected to have an insightful impact on hematology analyzers market by the end of forecast period. Moreover, advancements in software may help in reduction of instrument manufacturing cost, and allow development of auto-calibration, innovative self-troubleshooting, and other such advanced features.

Browse Research Report: http://bit.ly/2f0wFEm

Abbott, Inc., Agilent Technologies, Beckman Coulter, Inc., Drew Scientific, Inc. Grifols SA, Horiba, Ltd., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Hemosonics LLC, and Mindray Corporation are some of the key players in the global hemostasis analyzers market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.